Synflorix™ data collection

OTHER2 trials

Sponsors

GlaxoSmithKline

Conditions

Immunisation Against Streptococcus PneumoniaeInfections, Streptococcal

Unknown Phase

Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea

CompletedNCT01248988

GlaxoSmithKlineInfections, Streptococcal

Start: 2010-12-31End: 2015-09-30Updated: 2017-01-13

Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka

WithdrawnNCT01803425

GlaxoSmithKlineImmunisation Against Streptococcus Pneumoniae

Start: 2013-04-30End: 2014-04-30Updated: 2013-09-09

Related Papers

A 6-year safety surveillance of 10-valent pneumococcal non-typeable <i>Haemophilus influenzae</i> protein D conjugate vaccine (PHiD-CV) in South Korea

Human Vaccines & Immunotherapeutics2018-08-293 citations